A Six-Month Prospective Follow-Up Study of WB001

NCT05693792 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-05-06

No results posted yet for this study

Summary

This study is a 6-month follow-up study to WB001-001 conducted to assess and evaluate the durability of the effect of {WB001+TAU} beyond the 8-week treatment period.

Conditions

Interventions

OTHER

Observational

No treatment regimen will be deployed in this follow-up study.

Sponsors & Collaborators

  • Woebot Health

    lead INDUSTRY

Eligibility

Min Age
22 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2024-06-08
Completion
2024-06-08
FDA Device
Yes

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05693792 on ClinicalTrials.gov